enprofylline has been researched along with Kidney Failure, Chronic in 1 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have studied the pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis, patients with chronic renal failure, and healthy subjects, and have assessed the predictive value of routine tests of liver function and renal function (creatinine clearance) for theophylline and enprofylline total body clearances." | 7.67 | The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease. ( de Jong, PE; de Zeeuw, RA; Ekman, I; Gips, CH; Jonkman, JH; Koëter, GH; Kraan, J; van der Mark, TW, 1988) |
| "We have studied the pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis, patients with chronic renal failure, and healthy subjects, and have assessed the predictive value of routine tests of liver function and renal function (creatinine clearance) for theophylline and enprofylline total body clearances." | 3.67 | The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease. ( de Jong, PE; de Zeeuw, RA; Ekman, I; Gips, CH; Jonkman, JH; Koëter, GH; Kraan, J; van der Mark, TW, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kraan, J | 1 |
| Jonkman, JH | 1 |
| Koëter, GH | 1 |
| Gips, CH | 1 |
| de Jong, PE | 1 |
| van der Mark, TW | 1 |
| Ekman, I | 1 |
| de Zeeuw, RA | 1 |
1 other study available for enprofylline and Kidney Failure, Chronic
| Article | Year |
|---|---|
The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease.
Topics: Adult; Aged; Bronchodilator Agents; Female; Humans; Kidney Failure, Chronic; Kidney Function Tests; | 1988 |